19 results

1 Assessing frailty using comprehensive geriatric assessment in older patients with hematologic malignancy
Jung-Yeon Choi, Kwang-il Kim
KMSID: 1516078594   Blood Res. 2022;57(S1):1-5.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2021218
6 Evaluation and management of platelet transfusion refractoriness
Hee-Jeong Youk, Sang-Hyun Hwang, Heung-Bum Oh, Dae-Hyun Ko
KMSID: 1516078606   Blood Res. 2022;57(S1):6-10.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2021229
11 Diagnostic workup of inherited platelet disorders
Bohyun Kim
KMSID: 1516078595   Blood Res. 2022;57(S1):11-19.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2021223
20 Diagnosis and management of monoclonal gammopathy of clinical significance
Hyungwoo Cho
KMSID: 1516078599   Blood Res. 2022;57(S1):20-26.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022035
27 Update on the POEMS syndrome
Yu Ri Kim
KMSID: 1516078600   Blood Res. 2022;57(S1):27-31.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022001
32 FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
Jae-Sook Ahn, Hyeoung-Joon Kim
KMSID: 1516078601   Blood Res. 2022;57(S1):32-36.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022017
37 Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura
Sung Hwa Bae, Sung-Hyun Kim, Soo-Mee Bang
KMSID: 1516078602   Blood Res. 2022;57(S1):37-43.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022005
44 Challenging issues in the management of cancer-associated venous thromboembolism
Ho-Young Yhim
KMSID: 1516078603   Blood Res. 2022;57(S1):44-48.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022025
49 Overview of inherited bone marrow failure syndromes
Meerim Park
KMSID: 1516078604   Blood Res. 2022;57(S1):49-54.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022012
55 Basic immunohistochemistry for lymphoma diagnosis
Junhun Cho
KMSID: 1516078605   Blood Res. 2022;57(S1):55-61.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022037
62 Update on primary plasma cell leukemia
Sung-Hoon Jung, Je-Jung Lee
KMSID: 1516078607   Blood Res. 2022;57(S1):62-66.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022033
67 Human acute myeloid leukemia stem cells: evolution of concept
Dong-Yeop Shin
KMSID: 1516078608   Blood Res. 2022;57(S1):67-74.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2021221
75 Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT
Kwai Han Yoo
KMSID: 1516078609   Blood Res. 2022;57(S1):75-78.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022055
79 Diagnosis and management of thrombocytopenia in pregnancy
Young Hoon Park
KMSID: 1516078611   Blood Res. 2022;57(S1):79-85.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022068
86 Genetics and genomics of bone marrow failure syndrome
Hyun-Young Kim, Hee-Jin Kim, Sun-Hee Kim
KMSID: 1516078610   Blood Res. 2022;57(S1):86-92.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022056
93 Advances in laboratory assessment of thrombosis and hemostasis
Jaewoo Song
KMSID: 1516078612   Blood Res. 2022;57(S1):93-100.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022048
101 Advances in prophylaxis and treatment of invasive fungal infections: perspectives on hematologic diseases
Hyojin Ahn, Raeseok Lee, Sung-Yeon Cho, Dong-Gun Lee
KMSID: 1516078597   Blood Res. 2022;57(S1):101-111.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022036
112 Recent advances in treatments of adult immune thrombocytopenia
Dae Sik Kim
KMSID: 1516078596   Blood Res. 2022;57(S1):112-119.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022038
120 Treatment of indolent lymphoma
Seong Hyun Jeong
KMSID: 1516078598   Blood Res. 2022;57(S1):120-129.   Published online 2022 April 30    DOI: http://dx.doi.org/10.5045/br.2022.2022054
Articles from Blood Research are provided here courtesy of Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of